Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund.
Cerbone L, Delfanti S, Crivellari S, De Angelis AM, Mazzeo L, Proto C, Occhipinti M, Lo Russo G, Dellepiane C, Biello F, Alabiso I, Verderame F, Gauna R, De Simone I, Cuppone F, Petraglia S, Pasello G, Ceresoli GL, Garassino MC, Torri V, Grosso F.
Cerbone L, et al. Among authors: de angelis am.
Tumori. 2024 Feb 19:3008916241229287. doi: 10.1177/03008916241229287. Online ahead of print.
Tumori. 2024.
PMID: 38372045